Introduction
Despite declines, roughly one in nine adolescents was a daily tobacco smoker in 2008 (Johnston, O'Malley, Bachman, & personalized stress imagery technique (Sinha, 2009) . Participating adolescent smokers also entered a smoking cessation trial following completion of the stress induction paradigm, allowing for linking of data to cessation outcome. Finally, nonsmokers were included to test whether smoking status influenced stress-related inattention, response inhibition, and risk taking. We hypothesized that, following stress exposure, smokers would have more inattentive and response inhibition errors and take greater risks than nonsmokers. We also expected that smokers who were not abstinent at the end of the cessation trial would have greater stress-related increases in inattention, response inhibition, and risk taking.
Methods Participants
Participants were high-school students taking part in a 4-week smoking cessation trial (Cavallo et al., 2007; Krishnan-Sarin et al., 2006) . Smokers were eligible if they smoked ≥5 cigarettes daily and had urine cotinine levels ≥350 ng/ml (Graham Massey Analytical Labs ). Nonsmokers denied smoking in the past six months, smoked ≤5 cigarettes lifetime, and had urine cotinine levels ≤30 ng/ml.
Fifteen nonsmokers (8 male and 7 female) and 12 smokers (9 male and 3 female) were included in analyses. One female smoker was excluded because of an adverse reaction to the stress induction. Smokers (17.2 ± 0.84) were older than nonsmokers (15.7 ± 1.10; p = .001), with no gender differences by smoking status. Abstinence among smokers was determined at the end of four weeks of treatment and defined as 7-day self-report confirmed by urine cotinine <100 ng/ml; 5 of 12 smokers were abstinent. Abstinent smokers were slightly older (17.4 ± 0.55; 4 males and 1 female) than nonabstinent smokers (17.0 ± 1.00), but no significant differences were observed in age or gender by cessation outcome.
Measures
NicAlert Semi-quantitative Cotinine Immunoassay Strips (Craig Medical) confirmed smoking status and are a reliable and valid measure of recent smoking in adolescents .
Stress Visual Analogue Scale (VAS) assessed stress levels throughout the stress induction session. Participants reported their stress level by placing a mark on a 100-cm line with anchors ranging from "no sensation" to "strongest imaginable stress level of any kind."
Minnesota Nicotine Withdrawal Scale (MNWS; Hughes & Hatsukami, 1986 ) assessed symptoms of nicotine withdrawal, including craving and negative affect (e.g., depression, anxiety and anger, frustration or irritability). It has adequate to good internal consistency (Toll, O'Malley, McKee, Salovey, & Krishnan-Sarin, 2007) .
Conners ' Continuous Performance Test-II (CPT-II; Conners, 2000) assessed inattention (omission errors or failure to respond to target stimuli) and response inhibition (commission errors or response to infrequent nontarget stimuli). The CPT-II produces T-scores that are normed for age and gender; it is free from practice effects and appears to be reliable and valid (Conners, 2000) .
Balloon Analogue Risk Task (BART; Lejuez et al., 2002) assessed risk taking as the mean number of pumps on balloon trials that do not burst (adjusted pumps), which is the most common outcome measure (e.g., White, Lejuez, & de Wit, 2008) . The BART appears to be reliable and valid (Lejuez et al., 2003; White et al., 2008) . Participants were not paid for their performance on the BART.
Procedures
Adolescents who expressed an interest in participation were screened for inclusion over the telephone. Eligible smokers, through participation in the cessation trial, signed assent/consent prior to participation; passive parental permission procedures were used (Krishnan-Sarin et al., 2006) . Eligible nonsmokers and a parent/guardian met with study staff and signed consent or assent/permission forms prior to participation.
Baseline CPT-II and BART performance were obtained from smokers at an assessment visit. In that or a separate session, smokers participated in script development for the stress imagery paradigm. Nonsmokers completed the baseline CPT-II and BART trials and script development at a screening session. Two scripts were solicited from each participant: (a) one of the most stressful events they had experienced in the past year, and (b) a situation that they found relaxing. To avoid the confounding effects of tobacco use imagery, scripts did not involve tobacco use (Sinha, 2009; Sinha, Catapano, & O'Malley, 1999; Sinha et al., 2003) .
All participants took part in a second (stress induction) session. First, they completed the VAS and MNWS and then listened to audiotapes describing their stressful experience. At the beginning of all tapes, participants were instructed to "Close your eyes and imagine the situation as if it is happening right now." Participants then completed the VAS, MNWS, BART, and CPT-II and a VAS after CPT-II completion. Finally, participants listened to their relaxing script and completed a final VAS. All scripts were recorded by the same female research assistant, and each lasted 5 min (4:30 for the situation and 30 s for continued visualization).
After completion of the stress induction, smokers participated in the 4-week CM/CBT cessation protocol. Prior to quit day, all participants took part in a skill-building "Prep-to-Quit" session. Participants set a quit day within the next week at which point treatment began. All procedures were approved by the Human Investigation Committee of Yale University School of Medicine.
Data Analyses
Analysis of intervention fidelity, using the VAS and MNWS, was done using one-way analysis of variance (ANOVA), with Bonferroni corrections for multiple pairwise comparisons. Correlations were performed between age (Pearson) and gender (Spearman) and the outcome measures. Baseline and stress-related inattention, response inhibition, and risk taking were analyzed using one-way ANOVA, with separate analyses differing by between-subject factor (smoking status or abstinence status [smokers only]). For analyses of stress-related outcomes, the corresponding baseline variable was controlled for (i.e., for stress-related inattention, baseline inattention was a covariate) to isolate stress-induced effects.
Results

Baseline Assessment
Correlations indicated that inattentive (omission) errors and age were significantly related among the whole sample (r = .559; p = .004) and smokers (r = .678; p = .031); response inhibition (commission errors) and gender were correlated within the entire sample (r = .458; p = .021). Supplementary Table 1 (online only) captures all correlations. At baseline, smokers and nonsmokers differed on both inattention; F(1, 26) = 6.640, p = .017; partial h 2 = .224; and risk taking; F(1, 26) = 5.111, p = .033; partial h 2 = .176. Smokers were more inattentive (T-score = 51.48 ± 9.88) and risky (mean adjusted pumps = 40.13 ± 10.48) than nonsmokers (inattention T-score = 44.61 ± 2.71; mean adjusted pumps = 29.16 ± 13.72). Response inhibition (commission) errors did not differ by smoking status. Smokers who were abstinent and nonabstinent at the end of the cessation trial did not differ on any baseline measures (ps > .05).
Stress Induction Validity
Participants endorsed increases in stress on the VAS from preinduction (11.67 cm ± 15.67) to postinduction (31.0 cm ± 26.65; Bonferroni corrected p = .027); these stress levels had a nonsignificant decline to the end of the assessment battery (19.3 cm ± 18.70; Bonferroni corrected p = .108) and declined significantly after participants listened to their relaxing situation (7.24 cm ± 9.01; poststress to postrelaxation Bonferroni corrected p = .003; postassessment to postrelaxation Bonferroni corrected p = .005). Participants also evidenced significant increases in depression (p < .001), anger, frustration or irritability (p = .003), and anxiety (p = .043) on the MNWS from pre-to postinduction. These findings indicate that the stress induction was a valid manipulation, increasing stress levels across participants.
Stress-Related Differences by Smoking Status
After controlling for baseline performance differences between groups, poststress CPT-II commission (response inhibition) errors were found to differ by smoking status; F(1, 26) = 4.313, p = .050; partial h 2 = .164. Smokers had higher levels of commission errors (T-score = 55.97 ± 10.70) than nonsmokers (T-score = 44.96 ± 12.38), which is illustrated in Figure 1 . No stress-related differences by smoking status were observed for CPT-II inattentive errors or the BART (ps > .05).
Differences Within Smokers by End-of-Treatment Abstinence
Controlling for baseline performance (end-of-treatment abstinent smokers: 40.20 ± 14.48; nonabstinent smokers: 40.08 ± 7.85), the only significant abstinence-related finding was on the BART; F(1, 11) = 9.835, p = .012, partial h 2 = .522. At the post stressor assessment, smokers who were abstinent at the end of the smoking cessation trial engaged in fewer pumps (36.66 ± 13.25) than nonabstinent smokers (44.56 ± 7.53). This is illustrated in Figure 2 . Poststressor levels of commission and omission errors and stress-related changes in MNWS symptoms and the VAS did not differ by end-of-treatment abstinence status (ps > .05).
Discussion
In all, this pilot investigation supported several of the proposed hypotheses. First, smokers had higher levels of inattentive (omission) errors and engaged in greater levels of risk than nonsmokers at baseline. This is consistent with much of the established literature (e.g., Reynolds et al., 2007) . We also found that smokers committed greater levels of response inhibition (commission) errors after stress exposure after controlling for baseline differences in commission errors and risk taking. This suggests that stress decreases response inhibition in smokers but not in nonsmokers. While previous research indicates decreased response inhibition after experimental stress exposure (see Sinha, 2001) , this is the first study to demonstrate a difference by smoking status in adolescents. The results are also consistent with findings that greater perceived stress levels were significantly associated with greater risk taking among adolescents ; however, the current study is the first prospective examination of these relationships in adolescents. Together, these results indicate that preventive interventions need to target decreasing stress and increasing nonimpulsive stress coping in adolescent smokers.
Most importantly, we found preliminary evidence that adolescent smokers who achieved abstinence in a cessation program that took place after the stress induction paradigm appeared to decrease their engagement in risk taking, while smokers who did not achieve abstinence increased their risk taking following stress exposure. This is notable in contrast to the finding by Shiffman (2005) that day-to-day changes in stressors did not predict smoking relapse. Perhaps our findings indicate that it is not stress exposure per se but one's reaction to stress exposure and any consequent increases in risk taking that increase smoking relapse risk (Sinha, 2001) . That said, Shiffman's work examined adults and this examined adolescents, so developmental differences may also underlie discrepancies. Furthermore, nicotine withdrawal symptoms did not mediate this relationship as no significant interaction between nicotine withdrawal change (pre-to poststressor) and end-oftreatment abstinence was found. While in need of further study, these findings argue that addressing stress-related risk taking in adolescent smokers may help cessation attempts succeed.
Some limitations of this study should be noted. First, this is a pilot investigation with a small sample size, and hence, future replication with a larger sample size is warranted. Second, baseline CPT-II and BART performance were obtained on a different day than the stress induction session. This was done because of logistical issues, so some differences on the stress induction day could have been due to smoking or abstinence status; that said, controlling for baseline performance should have limited this. Finally, we did not control for gender in examining smoking status differences in response inhibition, despite a significant correlation. We did this because the CPT-II results are normed for gender and because of concerns about such analyses being underpowered. The current study, however, was strengthened by the use of a validated stress imagery paradigm by biochemical verification of smoking status and validated assessments of inattention, response inhibition, and risk taking.
These results indicate that stress-related increases in risk taking may mark increased risk for later cessation failure in adolescents. Given the small sample size, further investigations are needed that replicate these results and expand them to other developmental groups. In all, though, these findings provide evidence that intervention programs need to account for the relationships among stress, response inhibition, and risk taking to maximize their impact adolescent smoking rates.
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